These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
790 related articles for article (PubMed ID: 23435438)
1. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough? Feng W; Hua K; Malpica A; Zhou X; Baak JP Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438 [TBL] [Abstract][Full Text] [Related]
2. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study. Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015 [TBL] [Abstract][Full Text] [Related]
3. [Clinical review of 97 patients with endometrial stromal sarcoma]. Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):115-9. PubMed ID: 18683750 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors, treatment and outcome in a Turkish population with endometrial stromal sarcoma. Donertas A; Nayki U; Nayki C; Ulug P; Gultekin E; Yildirim Y Asian Pac J Cancer Prev; 2015; 16(3):881-7. PubMed ID: 25735377 [TBL] [Abstract][Full Text] [Related]
5. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group. Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825 [TBL] [Abstract][Full Text] [Related]
7. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943 [TBL] [Abstract][Full Text] [Related]
8. Low-Grade Endometrial Stromal Sarcoma - a Review. Thiel FC; Halmen S Oncol Res Treat; 2018; 41(11):687-692. PubMed ID: 30317238 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics, pathological reevaluation, surgical management and adjuvant therapy of patients with endometrial stromal tumors. Rothmund R; Hartkopf A; Joachim C; Walter CB; Wallwiener M; Kraemer B; Brucker SY; Staebler A; Taran FA Arch Gynecol Obstet; 2014 Dec; 290(6):1195-200. PubMed ID: 24981048 [TBL] [Abstract][Full Text] [Related]
10. Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma. Malouf GG; Duclos J; Rey A; Duvillard P; Lazar V; Haie-Meder C; Balleyguier C; Morice P; Lhommé C; Pautier P Ann Oncol; 2010 Oct; 21(10):2102-2106. PubMed ID: 20305035 [TBL] [Abstract][Full Text] [Related]
11. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma. Weitmann HD; Kucera H; Knocke TH; Pötter R Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935 [TBL] [Abstract][Full Text] [Related]
12. Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: A retrospective cohort study. Zhou J; Zheng H; Wu SG; He ZY; Li FY; Su GQ; Sun JY Int J Surg; 2015 Nov; 23(Pt A):147-51. PubMed ID: 26449652 [TBL] [Abstract][Full Text] [Related]
13. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran. Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014 [TBL] [Abstract][Full Text] [Related]
14. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study. Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565 [TBL] [Abstract][Full Text] [Related]
15. Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma? Barney B; Tward JD; Skidmore T; Gaffney DK Int J Gynecol Cancer; 2009 Oct; 19(7):1232-8. PubMed ID: 19823060 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study. Kuku S; Williams M; McCormack M Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205 [TBL] [Abstract][Full Text] [Related]
18. Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate? Comert GK; Turkmen O; Kar I; Yucel O; Kilic C; Boran N; Basaran D; Karalok A; Turan T J Chin Med Assoc; 2019 May; 82(5):385-389. PubMed ID: 31058712 [TBL] [Abstract][Full Text] [Related]
19. Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma? Karataşlı V; Çakır İ; Can B; Erkılınç S; Karadeniz T; Kuru O; Gökçü M; Sancı M J Obstet Gynaecol; 2021 Jul; 41(5):797-802. PubMed ID: 33063586 [TBL] [Abstract][Full Text] [Related]
20. Endometrial stromal sarcoma: prognostic factors and impact of adjuvant therapy in early stages. Tanz R; Mahfoud T; Bazine A; Aassab R; Benjaafar N; El Khalil El Gueddari B; Ichou M; Errihani H Hematol Oncol Stem Cell Ther; 2012; 5(1):31-5. PubMed ID: 22446608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]